Search

Your search keyword '"Kennedy, Catherine"' showing total 474 results

Search Constraints

Start Over You searched for: Author "Kennedy, Catherine" Remove constraint Author: "Kennedy, Catherine" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
474 results on '"Kennedy, Catherine"'

Search Results

1. Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma

3. Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis

4. p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

5. CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study

6. Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study

7. Profiling the immune landscape in mucinous ovarian carcinoma.

8. Gene expression profiling of mucinous ovarian tumors and comparison with upper and lower gastrointestinal tumors identifies markers associated with adverse outcomes.

9. Molecular subclasses of clear cell ovarian carcinoma and their impact on disease behavior and outcomes

10. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

11. Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions

12. DNA Methylation Profiles of Ovarian Clear Cell Carcinoma

13. Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer

14. Young Adolescents' Endorsement of Restrictive Gender Norms: Evidence from a Community-Based Intervention in Côte d'Ivoire and Sierra Leone

15. Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer

16. Therapist-Observer Concordance in Ratings of EBP Strategy Delivery: Challenges and Targeted Directions in Pursuing Pragmatic Measurement in Childrens Mental Health Services.

17. Therapist-Observer Concordance in Ratings of EBP Strategy Delivery: Challenges and Targeted Directions in Pursuing Pragmatic Measurement in Children’s Mental Health Services

18. Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)

19. The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer

23. Population based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high grade serous ovarian cancer

24. mTORC1 underlies age‐related muscle fiber damage and loss by inducing oxidative stress and catabolism

25. Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women

27. Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.

28. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.

29. Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer

30. Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

31. Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci

32. Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

33. Therapeutic options for mucinous ovarian carcinoma

34. FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer

35. Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

36. A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases

37. PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors

38. The lysosomal trafficking regulator "LYST": an 80-year traffic jam.

39. The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer

41. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

43. The molecular origin and taxonomy of mucinous ovarian carcinoma

45. MicroRNA-Related DNA Repair/Cell-Cycle Genes Independently Associated With Relapse After Radiation Therapy for Early Breast Cancer

46. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

48. Co-Occurring Health-Related Behavior Pairs in College Students: Insights for Prioritized and Targeted Interventions

50. Undergraduate Physical Activity and Depressive Symptoms: A National Study

Catalog

Books, media, physical & digital resources